Association of a structural variant within the SQSTM1 gene with amyotrophic lateral sclerosis

Julia Pytte, Ryan S Anderton, Loren L Flynn, Frances Theunissen, Leanne Jiang, Ianthe Pitout, Ian James, Frank L Mastaglia, Ann M Saunders, Richard Bedlack, Teepu Siddique, Nailah Siddique, P Anthony Akkari, Julia Pytte, Ryan S Anderton, Loren L Flynn, Frances Theunissen, Leanne Jiang, Ianthe Pitout, Ian James, Frank L Mastaglia, Ann M Saunders, Richard Bedlack, Teepu Siddique, Nailah Siddique, P Anthony Akkari

Abstract

Objective: As structural variations may underpin susceptibility to complex neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), the objective of this study was to investigate a structural variant (SV) within sequestosome 1 (SQSTM1).

Methods: A candidate insertion/deletion variant within intron 5 of the SQSTM1 gene was identified using a previously established SV evaluation algorithm and chosen according to its subsequent theoretical effect on gene expression. The variant was systematically assessed through PCR, polyacrylamide gel fractionation, Sanger sequencing, and reverse transcriptase PCR.

Results: A reliable and robust assay confirmed the polymorphic nature of this variant and that the variant may influence SQSTM1 transcript levels. In a North American cohort of patients with familial ALS (fALS) and sporadic ALS (sALS) (n = 403) and age-matched healthy controls (n = 562), we subsequently showed that the SQSTM1 variant is associated with fALS (p = 0.0036), particularly in familial superoxide dismutase 1 mutation positive patients (p = 0.0005), but not with patients with sALS (p = 0.97).

Conclusions: This disease association highlights the importance and implications of further investigation into SVs that may provide new targets for cohort stratification and therapeutic development.

Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.

Figures

Figure 1. Characterization of the SQSTM1 variant
Figure 1. Characterization of the SQSTM1 variant
(A) PCR and native polyacrylamide gel electrophoresis across a random selection of control DNA samples and compared against a 100bp ladder. (B) Sanger sequencing of the I allele and D allele. (C) SQSTM1 transcript levels of SQSTM1 exon 4–7 analyzed using RT-PCR on RNA from a panel of control ONS cells. Relative densitometry was calculated with SQSTM1 transcript signal standardized to each respective GAPDH signal. GAPDH = glyceraldehyde 3-phosphate dehydrogenase; I/D = insertion/deletion; ONS = olfactory neurosphere derived cells; RT-PCR = Reverse transcriptase PCR; SQSTM1 = sequestosome 1.
Figure 2. Association of the SQSTM1 variant…
Figure 2. Association of the SQSTM1 variant with age at onset of disease and survival
(A) The median and distribution of age at onset (years) of SOD1 mutation-positive patients with ALS (n = 167) grouped by each SQSTM1 variant genotype. (B) Kaplan-Meier survival curves of SOD1 mutation-positive patients, comparing the SQSTM1 genotypes assuming independent measurements. A robust log-rank test accounting for familial correlation was performed to assess any association between the groups. Survival was measured in months from ALS diagnosis until death. ALS = amyotrophic lateral sclerosis; SOD1 = superoxide dismutase 1; SQSTM1 = sequestosome 1.

References

    1. Chakravarti A, Kapoor A. Mendelian puzzles. Science 2012;335:930–931.
    1. Feuk L, Carson AR, Scherer SW. Structural variation in the human genome. Nat Rev Genet 2006;7:85–97.
    1. Stankiewicz P, Lupski JR. Structural variation in the human genome and its role in disease. Annu Rev Med 2010;61:437–455.
    1. Lupski JR. Structural variation mutagenesis of the human genome: impact on disease and evolution. Environ Mol Mutagen 2015;56:419–436.
    1. Lyall DM, Royle NA, Harris SE, et al. . Alzheimer's disease susceptibility genes APOE and TOMM40, and hippocampal volumes in the Lothian birth cohort 1936. PLoS One 2013;8:e80513.
    1. Lutz MW, Saul R, Linnertz C, et al. . A cytosine-thymine (CT)-rich haplotype in intron 4 of SNCA confers risk for Lewy body pathology in Alzheimer's disease and affects SNCA expression. Alzheimers Dement 2015;11:1133–1143.
    1. Linnertz C, Anderson L, Gottschalk W, et al. . The cis-regulatory effect of an Alzheimer's disease-associated poly-T locus on expression of TOMM40 and apolipoprotein E genes. Alzheimers Dement 2014;10:541–551.
    1. Fecto F, Yan J, Vemula SP, et al. . SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch Neurol 2011;68:1440–1446.
    1. Rea SL, Majcher V, Searle MS, Layfield R. SQSTM1 mutations—bridging paget disease of bone and ALS/FTLD. Exp Cell Res 2014;325:27–37.
    1. Zatloukal K, Stumptner C, Fuchsbichler A, et al. . p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases. Am J Pathol 2002;160:255–263.
    1. Lowe J, Blanchard A, Morrell K, et al. . Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and mallory bodies in alcoholic liver disease. J Pathol 1988;155:9–15.
    1. Nogalska A, Chiara AE, Ae T, et al. . p62/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis. Acta Neuropathol 2009;118:407–413.
    1. Kwok CT, Morris A, de Belleroche JS. Sequestosome-1 (SQSTM1) sequence variants in ALS cases in the UK: prevalence and coexistence of SQSTM1 mutations in ALS kindred with PDB. Eur J Hum Genet 2014;22:492–496.
    1. Kirkin V, McEwan DG, Novak I, Dikic I. A Role for ubiquitin in selective autophagy. Mol Cell 2009;34:259–269.
    1. Welchman RL, Gordon C, Mayer RJ. Ubiquitin and ubiquitin-like proteins as multifunctional signals. Nat Rev Mol Cell Biol 2005;6:599–609.
    1. Rogov V, Dötsch V, Johansen T, Kirkin V. Interactions between autophagy receptors and ubiquitin-like proteins form the molecular basis for selective autophagy. Mol Cell 2014;53:167–178.
    1. Pankiv S, Clausen TH, Lamark T, et al. . p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 2007;282:24131–24145.
    1. Saul R, Lutz MW, Burns DK, Roses AD, Chiba-Falek O. The SSV evaluation system: a tool to prioritize short structural variants for studies of possible regulatory and causal variants. Hum Mutat 2016;37:877–883.
    1. Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Mot Neuron Disord 2000;1:293–299.
    1. Chaisson MJP, Sanders AD, Zhao X, et al. . Multi-platform discovery of haplotype-resolved structural variation in human genomes. Nat Commun 2019;10:1784.
    1. Sudmant PH, Rausch T, Gardner EJ, et al. . An integrated map of structural variation in 2,504 human genomes. Nature 2015;526:75–81.
    1. Roses AD. Short sequence variations (SSVs) may explain multiplicity of SOD1-SNP mutations in Amyotrophic Lateral Sclerosis. Presented at the 66th Annual Meeting American Society of Human Genetics; October 19, 2016; Vancouver.
    1. Roses AD, Akkari PA, Chiba-Falek O, et al. . Structural variants can be more informative for disease diagnostics, prognostics and translation than current SNP mapping and exon sequencing. Expert Opin Drug Metab Toxicol 2016;12:135–147.
    1. Frazer KA, Murray SS, Schork NJ, Topol EJ. Human genetic variation and its contribution to complex traits. Nat Rev Genet 2009;10:241–251.
    1. Li YC, Korol AB, Fahima T, Nevo E. Microsatellites within genes: structure, function, and evolution. Mol Biol Evol 2004;21:991–1007.
    1. De Jesus-Hernandez M, Mackenzie IR, Boeve BF, et al. . Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-Linked FTD and ALS. Neuron 2011;72:245–256.
    1. Gijselinck I, Van Langenhove T, van der Zee J, et al. . A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Lancet Neurol 2012;11:54–65.
    1. Renton AE, Majounie E, Waite A, et al. . A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011;72:257–268.
    1. Sproviero W, Shatunov A, Stahl D, et al. . ATXN2 trinucleotide repeat length correlates with risk of ALS. Neurobiol Aging 2017;51:178.e-1–178.
    1. Roses AD, Lutz MW, Amrine-Madsen H, et al. . A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease. Pharmacogenomics J 2010;10:375–384.
    1. Deng HX, Chen W, Hong ST, et al. . Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature 2011;477:211–215.
    1. Doi H, Adachi H, Katsuno M, et al. . p62/SQSTM1 differentially removes the toxic mutant androgen receptor via autophagy and inclusion formation in a spinal and bulbar muscular atrophy mouse model. J Neurosci 2013;33:7710–7727.
    1. Hadano S, Mitsui S, Pan L, et al. . Functional links between SQSTM1 and ALS2 in the pathogenesis of ALS: cumulative impact on the protection against mutant SOD1-mediated motor dysfunction in mice. Hum Mol Genet 2016;25:3321–3340.
    1. Mitsui S, Otomo A, Nozaki M, et al. . Systemic overexpression of SQSTM1/p62 accelerates disease onset in a SOD1 H46R-expressing ALS mouse model. Mol Brain 2018;11:1–16.
    1. Gal J, Strom A-L, Kwinter DM, et al. . Sequestosome 1/p62 links familial ALS mutant SOD1 to LC3 via a ubiquitin-independent mechanism. J Neurochem 2009;111:1062–1073.
    1. Zhou L, Wang H, Ren H, et al. . Bcl-2-dependent upregulation of autophagy by sequestosome 1/p62 in vitro. Acta Pharmacol Sin 2013;34:651–656.
    1. Féron F, Perry C, Girard SD, Mackay-Sim A. Isolation of adult stem cells from the human olfactory mucosa. In: Reynolds B, Deleyrolle L, editors. Methods in Molecular Biology. New Jersey: Humana Press; 2013:107–113.
    1. Matigian N, Abrahamsen G, Sutharsan R, et al. . Disease-specific, neurosphere-derived cells as models for brain disorders. Dis Model Mech 2010;3:785–798.
    1. Teyssou E, Takeda T, Lebon V, et al. . Mutations in SQSTM1 encoding p62 in amyotrophic lateral sclerosis: genetics and neuropathology. Acta Neuropathol 2013;125:511–522.
    1. Le Ber I, Camuzat A, Guerreiro R, et al. . SQSTM1 mutations in French patients with frontotemporal dementia or frontotemporal dementia with amyotrophic lateral sclerosis. JAMA Neurol 2013;70:1403–1410.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever